Jejunoileal Bypass

Subscribe to Selected New Research on Jejunoileal Bypass

838 relevant articles (26 outcomes, 39 trials/studies) found for this Therapy

Description: A procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.

Also Known As:

Jejuno-Ileal Bypass; Bypass, Ileojejunal; Bypass, Intestinal; Bypass, Jejuno-Ileal; Bypass, Jejunoileal; Bypasses, Ileojejunal; Bypasses, Intestinal; Bypasses, Jejuno-Ileal; Bypasses, Jejunoileal; Ileojejunal Bypasses; Intestinal Bypasses; Jejuno Ileal Bypass; Jejuno-Ileal Bypasses; Jejunoileal Bypasses; Ileojejunal Bypass; Intestinal Bypass

Relationship Network

Therapy Context: Research Results

Therapeutics: 5229

Bariatrics: 6

Bariatric Surgery: 1164

Jejunoileal Bypass: 838

Operative Surgical Procedures: 4

Bariatric Surgery: 1164

Jejunoileal Bypass: 838

Surgical Anastomosis: 83

Jejunoileal Bypass: 838

Digestive System Surgical Procedures: 10

Jejunoileal Bypass: 838

Experts

1.	Badiali, M: 2 articles (12/2004 - 08/2001)
2.	Westhovens, René: 1 article (10/2008)
3.	Cosyn, Luc: 1 article (10/2008)
4.	Bammens, Bert: 1 article (10/2008)
5.	Goovaerts, Gerda: 1 article (10/2008)
6.	Vanrenterghem, Yves: 1 article (10/2008)
7.	Cornelis, Tom: 1 article (10/2008)
8.	Lerut, Evelyne: 1 article (10/2008)
9.	Ibanez Bosch, R: 1 article (03/2008)
10.	Del Val Del Amo, N: 1 article (03/2008)

Related Diseases

1.	Morbid Obesity 12/01/1979 - "Jejunoileal bypass for morbid obesity with our current bowel length dimensional considerations has achieved good results in 74 per cent of patients" 06/01/2004 - "BACKGROUND: Bariatric operations are currently the only effective treatment for morbid obesity The first operation, jejunoileal bypass (JIB), has been superceded" 07/01/1986 - "Although jejunoileal bypass surgery proved effective in controlling morbid obesity, the serious adverse effects from the operation were ultimately found to outweigh the benefits" 07/01/1982 - "If the decreased food intake in humans after intestinal bypass is due to a similar mechanism, the possibility exists that this humoral appetite-suppressant factor may be clinically useful in the treatment of morbid obesity." 09/01/1984 - "Gastric partitioning is a safe and effective alternative to jejunoileal bypass in the control of morbid obesity" Order ALL the reference details at left...
2.	Weight Loss (Weight Reduction) 01/01/1977 - "Good results marked by weight reduction to the range of ideal weight without significant electrolyte or metabolic aberrations was observed in 82% of the patients receiving the current dimensional modificatiom of end-to-end jejunoileal bypass (30 cm to 20cm)" 03/01/1988 - "This operation gives improved weight loss when compared with gastroplasty or gastric bypass alone and has none of the late complications associated with intestinal bypass." 07/01/1976 - "Weight reduction as a result of jejunoileal bypass surgery brings about an improvement in pulmonary function." 12/01/2004 - "AIM OF THE STUDY: To evaluate reduction of risk factors for CVDs in morbid-obese patients (body mass index (BMI)>40 kg/m2) after weight loss upon bariatric surgery intervention of biliary-intestinal bypass" 12/01/1979 - "The present studies were designed to compare physiological and behavioral changes produced by weight loss induced with dieting and the weight loss which follows intestinal bypass" Order ALL the reference details at left...
3.	Obesity 10/01/2001 - "BACKGROUND: Bilio-intestinal bypass (BIB) is effective for the treatment of refractory obesity" 01/01/1977 - "Improvement in quality of life following jejunoileal bypass surgery for obesity." 01/01/1986 - "With the aid of the national Medical Birth Registries and Discharge Registries in Denmark and Sweden it was possible to identify and study delivery outcome in 77 women who, prior to pregnancy, had undergone an intestinal bypass operation for obesity" 02/01/1980 - "Jejunoileal bypass for obesity--what can we learn from a literature study?" 08/04/1978 - "A retrospective interview study was undertaken of 14 spousal pairs in which one member had undergone the intestinal bypass procedure for massive obesity" Order ALL the reference details at left...
4.	Liver Failure 03/01/1979 - "Although previous reports indicate that patients usually die when they develop liver failure of this severity after jejunoileal bypass, prolonged intensive nutritional repletion was associated with sufficient clinical and histologic improvement in these two patients so that intestinal reanastomosis could be performed safely." 09/01/2006 - "BACKGROUND: One of the reasons why jejunoileal bypass (JIB) was abandoned were reports of liver failure" 10/01/2001 - "BACKGROUND: Biliopancreatic diversion (BPD) was designed to avoid the serious complications of jejunoileal bypass (steatohepatitis and hepatic failure)" 04/01/1986 - "The most feared complication of the jejunoileal bypass is severe hepatic failure, which appeared in 2.3% of the cases, only after the end-to-end jejunoileal bypass, and never more than 12 months after surgery" 01/01/1981 - "Liver failure after jejunoileal bypass: an appraisal." Order ALL the reference details at left...
5.	Liver Diseases (Liver Disease) 08/01/1980 - "Jejunoileal bypasses were performed in rats to determine the effect of improved absorption on the development of liver dysfunction occurring after this procedure" 08/01/1980 - "Effect of improved absorption on development of jejunoileal bypass-induced liver dysfunction in rats." 08/01/1987 - "The objective of this study was to investigate whether alcohol administration exerts a synergistic effect on jejunoileal bypass-induced liver dysfunction in rats" 04/01/1981 - "Several recent studies suggest that jejunoileal bypass-induced liver disease results from malabsorption of essential nutrients" 08/01/2007 - "The classic procedure, jejunoileal bypass, has many complications including rapid progress of liver disease" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Calcium
2.	Calcium Oxalate
3.	tranilast (N 5')
4.	Glucose (Dextrose)
5.	Bile Acids and Salts (Bile Acids)
6.	Anti-Bacterial Agents (Antibiotics)
7.	Peptides
8.	Carrier Proteins (Binding Protein)
9.	brushite
10.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Gastric Bypass (Roux-en-Y Gastric Bypass)
2.	Gastroplasty (Vertical-Banded Gastroplasty)
3.	Gastrectomy
4.	Bariatric Surgery
5.	Biliopancreatic Diversion

Best Treatments:
Research Summary Report
on Morbid Obesity

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 98 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>